# A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers

> **NCT01675518** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 56 (actual)

## Conditions studied

- Healthy
- Pharmacokinetics of ASP7991

## Interventions

- **DRUG:** ASP7991
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01675518
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2012-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675518, "A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01675518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*